Advances in GLP-1 treatment: focus on oral semaglutide

There is currently a large arsenal of antidiabetic drugs available to treat type 2 diabetes (T2D). However, this is a serious chronic disease that affects millions of adults worldwide and is responsible for se...

Source: Diabetology and Metabolic Syndrome - September 15, 2021 Category: Endocrinology Authors: Freddy G. Eliaschewitz and Luis Henrique Canani Tags: Review Source Type: research